All 22 patients of the STR1VE-US study showed adverse events, of which 10 (45%) had some form of serious adverse event and 3 (14%) had serious treatment-related adverse events (two had an increase in ALT and AST and another had hydrocephalus) [30]. Here, GPT is linked to Hydrocephalus.